Matthew Stephen Young is Director & 10% Owner at Nutex Health, Inc. (NUTX). They have made 1 open-market trade across 1 company since 2022, most recently 2022-12-13.
CIK 0001920043
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NUTX | 41,964,832 | $7.8B |
Shares reported on the most recent Form 4, priced at the 2022-12-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NUTX | SELL | 2022-12-12 | 2022-12-14 | $2.17 | $735K | -4.2% | -10.9% | -41.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.